| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |